An Analytical Study of Iboga Alkaloids Contained in Tabernanthe iboga-Derived Products Offered by Ibogaine Treatment Providers

Bouso, José Carlos, Fornís, Ivan, Ventura Vilamala, Mireia, De Loenen, Benjamin, Sainz-Cort, Alberto, Jiménez-Garrido, Daniel F., Dos Santos, Rafael Guimarães, Hallak, Jaime E. C., Alcázar-Córcoles, Miguel Ángel, Jenks, Christopher W. · 2020 · Archives of Clinical Psychiatry

AI-extracted · unverified · confirm at source

CRITICAL: n=16 products from 5 vendors - purity ranged 0-73.4% ibogaine. One sample contained ZERO ibogaine. Extreme variability makes dose calculation impossible without analysis.

Dosing: Product analysis only — ibogaine content ranged 0.6%–73.7% across 16 samples; therapeutic dose calculation requires independent GC/MS verification (oral)

Sample size: 16

Contraindications: Unverified ibogaine product purity (0-73% range found across vendors)